Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BiondVax Pharmaceuticals Ltd. | Director | Ordinary Shares | 66.8K | Jan 1, 2023 | Direct | ||
POINT Biopharma Global Inc. | Director | Common Stock | 0 | $12.45 | Dec 27, 2023 | Direct | |
POINT Biopharma Global Inc. | Director | Stock Option (Right to Buy) | 0 | Dec 27, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PNT | POINT Biopharma Global Inc. | Dec 27, 2023 | 4 | $0 | 4 | Dec 27, 2023 | Director |
PNT | POINT Biopharma Global Inc. | Jun 1, 2023 | 1 | $0 | 4 | Jun 5, 2023 | Director |
BVXV | BiondVax Pharmaceuticals Ltd. | Jan 1, 2023 | 0 | $0 | 3/A | Jan 23, 2023 | Director |
PNT | POINT Biopharma Global Inc. | Nov 21, 2022 | 1 | $11.2K | 4 | Nov 23, 2022 | Director |
PNT | POINT Biopharma Global Inc. | Jun 2, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
PNT | POINT Biopharma Global Inc. | Jul 6, 2021 | 1 | $0 | 4 | Jul 8, 2021 | Director |
PNT | POINT Biopharma Global Inc. | Jun 30, 2021 | 0 | $0 | 3 | Jun 30, 2021 | Director |